| Zacks Company Profile for Assembly Biosciences, Inc. (ASMB : NSDQ) |
|
|
| |
| • Company Description |
| Assembly Biosciences, Inc. is a biopharmaceutical company. It develops therapies for infectious diseases and other disorders of the gastrointestinal (GI) system. Assembly's product portfolio consists of two late stage assets: VEN 307 for relief from pain associated with anal fissures and VEN 308 for the treatment of fecal incontinence. The Company is also developing novel microbiome-based technology for targeted oral delivery of therapeutic bacteria, complex proteins, viral antigens and small molecules to treat intractable infectious diseases of the GI tract, such as C. difficile infections. Assembly Biosciences Inc., formerly known as Ventrus Biosciences, Inc., is based in New York.
Number of Employees: 73 |
|
|
| |
| • Price / Volume Information |
| Yesterday's Closing Price: $18.14 |
Daily Weekly Monthly
 |
| 20 Day Moving Average: 39,783 shares |
| Shares Outstanding: 7.64 (millions) |
| Market Capitalization: $138.54 (millions) |
| Beta: 0.62 |
| 52 Week High: $19.93 |
| 52 Week Low: $7.75 |
| Short Interest Ratio: |
| |
% Price Change |
% Price Change Relative to S&P 500 |
| 4 Week |
11.70% |
6.74% |
| 12 Week |
99.78% |
70.64% |
| Year To Date |
14.96% |
7.67% |
|
|
|
|
| |
|
|
| |
| • General Corporate Information |
Officers
Jason A. Okazaki - Chief Executive Officer; President and Director
William R. Ringo - Chairman
Jeanette M. Bjorkquist - Executive Director; Accounting and Treasury
Anthony E. Altig - Director
Tomas Cihlar - Director
|
|
Peer Information
Assembly Biosciences, Inc. (BGMR)
Assembly Biosciences, Inc. (BBIO)
Assembly Biosciences, Inc. (IPAH)
Assembly Biosciences, Inc. (BRL)
Assembly Biosciences, Inc. (BHC)
Assembly Biosciences, Inc. (AKRXQ)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-GENERIC DRG
Sector: Medical
CUSIP: 045396207
SIC: 2834
|
|
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 08/14/25
|
|
Share - Related Items
Shares Outstanding: 7.64
Most Recent Split Date: 2.00 (0.08:1)
Beta: 0.62
Market Capitalization: $138.54 (millions)
|
|
|
|
|
| |
| • EPS Information |
• Dividend Information |
| Analyst Coverage: No |
Dividend Yield: 0.00% |
| Current Fiscal Quarter EPS Consensus Estimate: $ |
Indicated Annual Dividend: $0.00 |
| Current Fiscal Year EPS Consensus Estimate: $ |
Payout Ratio: |
| Number of Estimates in the Fiscal Year Consensus: |
Change In Payout Ratio: |
| Estmated Long-Term EPS Growth Rate: % |
Last Dividend Paid: NA - $0.00 |
| Next EPS Report Date: 08/14/25 |
|
|
|
| |
